Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SUN PHARMA AUROBINDO PHARMA/
SUN PHARMA
 
P/E (TTM) x 13.8 52.8 26.1% View Chart
P/BV x 1.4 4.5 30.2% View Chart
Dividend Yield % 1.6 1.1 142.3%  

Financials

 AUROBINDO PHARMA   SUN PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
SUN PHARMA
Mar-22
AUROBINDO PHARMA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,064931 114.3%   
Low Rs584593 98.6%   
Sales per share (Unadj.) Rs400.3161.1 248.5%  
Earnings per share (Unadj.) Rs45.714.2 322.0%  
Cash flow per share (Unadj.) Rs64.923.1 280.8%  
Dividends per share (Unadj.) Rs9.0010.00 90.0%  
Avg Dividend yield %1.11.3 83.2%  
Book value per share (Unadj.) Rs419.4200.1 209.6%  
Shares outstanding (eoy) m585.942,399.34 24.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.14.7 43.5%   
Avg P/E ratio x18.053.7 33.6%  
P/CF ratio (eoy) x12.732.9 38.5%  
Price / Book Value ratio x2.03.8 51.6%  
Dividend payout %19.770.4 27.9%   
Avg Mkt Cap Rs m482,7991,827,693 26.4%   
No. of employees `000NANA-   
Total wages/salary Rs m34,50973,008 47.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,555386,545 60.7%  
Other income Rs m3,22614,374 22.4%   
Total revenues Rs m237,781400,919 59.3%   
Gross profit Rs m42,56653,150 80.1%  
Depreciation Rs m11,26521,437 52.5%   
Interest Rs m4861,274 38.2%   
Profit before tax Rs m34,04044,813 76.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,25610,755 67.5%   
Profit after tax Rs m26,78434,058 78.6%  
Gross profit margin %18.113.7 132.0%  
Effective tax rate %21.324.0 88.8%   
Net profit margin %11.48.8 129.6%  
BALANCE SHEET DATA
Current assets Rs m181,227350,150 51.8%   
Current liabilities Rs m81,560172,006 47.4%   
Net working cap to sales %42.546.1 92.2%  
Current ratio x2.22.0 109.2%  
Inventory Days Days25149 16.8%  
Debtors Days Days62100 62.4%  
Net fixed assets Rs m155,104318,882 48.6%   
Share capital Rs m5862,399 24.4%   
"Free" reserves Rs m245,174477,713 51.3%   
Net worth Rs m245,760480,112 51.2%   
Long term debt Rs m2,4922,299 108.4%   
Total assets Rs m336,331669,032 50.3%  
Interest coverage x71.036.2 196.1%   
Debt to equity ratio x00 211.7%  
Sales to assets ratio x0.70.6 120.7%   
Return on assets %8.15.3 153.5%  
Return on equity %10.97.1 153.6%  
Return on capital %13.99.6 145.6%  
Exports to sales %31.10-   
Imports to sales %11.90-   
Exports (fob) Rs m72,862NA-   
Imports (cif) Rs m27,965NA-   
Fx inflow Rs m77,245106,331 72.6%   
Fx outflow Rs m31,52471,874 43.9%   
Net fx Rs m45,72134,456 132.7%   
CASH FLOW
From Operations Rs m50,16589,845 55.8%  
From Investments Rs m-32,116-57,247 56.1%  
From Financial Activity Rs m-29,693-51,935 57.2%  
Net Cashflow Rs m-11,674-17,648 66.1%  

Share Holding

Indian Promoters % 48.8 54.5 89.5%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 34.6 109.8%  
FIIs % 20.7 15.0 138.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 45.5 105.8%  
Shareholders   359,684 647,167 55.6%  
Pledged promoter(s) holding % 15.9 4.0 394.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    LUPIN    PIRAMAL ENTERPRISES    



Today's Market

Sensex Tanks 652 Points, Nifty Ends Below 17,800; IndusInd Bank & Bajaj Finserv Top Losers(Closing)

After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.